FH25: Individual centric investing with Steve Seuntjens
Newsletters and Deep Dive digital magazine
Intellia has reported the first-ever phase 3 results with an in vivo gene-editing therapy, CRISPR-based lonvo-z for hereditary angioedema.
At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox